您搜索了: nevropatijo (斯洛文尼亚语 - 英语)

imajo avtonomno nevropatijo,
in whom an autonomic neuropathy is present,

ki imajo avtonomno nevropatijo,
in whom an autonomic neuropathy is present,

vnetje živcev, ki lahko povzroči nevropatijo,
inflammation of the nerves that can lead to neuropathy

zdravila, za katera je znano, da povzročajo periferno nevropatijo
medicinal products known to cause peripheral neuropathy

nevropatijo so zdravili s podpornim zdravljenjem in z drugimi načini.
neuropathy has been managed with supportive care and other therapies.

periferno nevropatijo) bolezni dihal, prsnega koša in mediastinalnega prostora
peripheral neuropathy) respiratory, thoracic and mediastinal disorders

doksazosin je treba pri bolnikih z diabetično avtonomno nevropatijo uporabljati previdno.
doxazosin should be used with care in patients with diabetic autonomic neuropathy.

44 odstotkov bolnikov je imelo simptome, ki jih lahko povežemo z nevropatijo.
forty-four percent of patients experienced symptoms that could be associated with neuropathy; most were mild to moderate and were reversible upon cessation of treatment with trisenox.

2 periferna nevropatija ovrednotena z uporabo smq za nevropatijo (razširjeni okvir).
2 peripheral neuropathy is evaluated using the smq neuropathy (broad scope)

v tretjo in četrto študijo je bilo vključenih skupno 28 bolnikov z multifokalno motorično nevropatijo.
the third and fourth studies were in a total of 28 patients with mmn.

bolniki s potekajočo periferno nevropatijo ≥ 2. stopnje so bili izključeni iz kliničnih študij.
patients with ongoing peripheral neuropathy ≥grade 2 were excluded from clinical studies.

bolnike z obstoječo hudo nevropatijo lahko zdravite z zdravilom velcade šele po skrbnem pretehtanju razmerja koristi in tveganj.
patients with pre-existing severe neuropathy may be treated with velcade only after careful risk/ benefit assessment.

antiholinergična zdravila je treba uporabljati previdno pri bolnikih z avtonomno nevropatijo, kognitivno okvaro ali parkinsonovo boleznijo.
anticholinergic medicinal products should be used with caution in patients who have autonomic neuropathy, cognitive impairment or parkinson's disease.

chmp je bil zadovoljen s študijami pri bolnikih z multifokalno motorično nevropatijo, v katerih se je zdravilo kiovig izkazalo kot učinkovito.
the chmp was satisfied with the studies in patients with mmn, where kiovig was shown to be effective.

bolniki, ki imajo periferno nevropatijo ≥ 2. stopnje, so bili izključeni iz kliničnih študij s pomalidomidom.
patients with ongoing ≥grade 2 peripheral neuropathy were excluded from clinical studies with pomalidomide.

v primeru suma na periferno nevropatijo je treba ponovno pretehtati zdravljenje s telbivudinom (glejte poglavje 4.8).
if peripheral neuropathy is suspected, treatment with telbivudine should be reconsidered (see section 4.8).

bolnike s predhodno nevropatijo ≥ 2. stopnje ali resnimi medicinskimi dejavniki tveganja v zvezi s katerim koli pomembnim organskim sistemom so izključili.
patients with pre-existing neuropathy of grade ≥ 2 or serious medical risk factors involving any of the major organ systems were excluded.

bolniki z redko boleznijo, za katero je značilna počasi napredujoča asimetrična oslabelost udov brez čutilne izgube (multifokalno motorično nevropatijo, mnn).
patients who suffer from a rare condition characterized by slow progressive asymmetrical weakness of limbs without sensory loss (multifocal motor neuropathy, mmn).

drugi neželeni učinki vključujejo toksičnost za ledvice, povišane aminotransferaze, alopecijo, utrujenost, dehidracijo, izpuščaj, okužbo/sepso in nevropatijo.
other undesirable effects include renal toxicities, increased aminotransferases, alopecia, fatigue, dehydration, rash, infection/sepsis and neuropathy.

drugi neželeni učinki vključujejo toksičnost za ledvice, povišane vrednosti aminotransferaze, alopecijo, utrujenost, dehidracijo, izpuščaj, okužbo/sepso in nevropatijo.
other undesirable effects include renal toxicities, increased aminotransferases, alopecia, fatigue, dehydration, rash, infection/sepsis and neuropathy.